D&D Pharmatech

Founders Kang Choon Lee Seulki Lee Viktor Roschke

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$36M
Portfolio companies 1
Rounds per year 0.14
Lead investments 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
Summary

In 2014 was created D&D Pharmatech, which is appeared as Corporate Investor. The venture was found in Asia in South Korea. The leading representative office of defined Corporate Investor is situated in the Seongnam.

The important activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.

Among the various public portfolio startups of the fund, we may underline Neuraly Among the most successful fund investment fields, there are Health Care, Biotechnology. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - United States.

The current fund was established by Kang Choon Lee, Seulki Lee, Viktor Roschke.

The usual cause for the fund is to invest in rounds with 9 partakers. The meaningful sponsors for the fund in investment in the same round are Smilegate Investment, Octave Life Sciences, Maryland Venture Fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of D&D Pharmatech:
Typical Co-investors
D&D Pharmatech is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after D&D Pharmatech:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AfterDox HaMerkaz, Israel, Kfar Saba
Banca Sella Group Biella, Italy, Piemonte
Digital Sandbox KC Kansas City, Missouri, United States
ESID -
GFH Financial Group Bahrain, Capital Governorate, Manama
Gibralt Capital Corporation British Columbia, Canada, Vancouver
GP Investments Bermuda, Hamilton
Guangzhou Yuexiu Financial Holdings China, Guangdong, Guangzhou
Hambledon Capital -
Hangzhou Beida Touzi Guanli China, Hangzhou, Zhejiang
La Costa Investment Group California, San Diego, United States
Navlok Ventures Lewisville, Texas, United States
Noblelift Intelligent Equipment Changxing, China, Zhejiang
Quadrant Central, Central Region, Singapore
Raptor Consumer Partners New York, New York, United States
RElab England, London, United Kingdom
Saba Investments -
Sercel Carquefou, France, Pays de la Loire
Tchoupitoulas Partners Houston, Texas, United States
Technologieholding Bayern, Germany, Munich

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Neuraly

Biotechnology
Health Care
$36M18 Jul 2018 Maryland, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent D&D Pharmatech?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: